# Is Q2B Copenhagen 2026 Europe's Most Consequential Quantum Summit This Autumn?

QC Ware's Q2B Copenhagen Conference opens in **19 days** — September 9–10, 2026 at Øksnehallen in Copenhagen — making it the most densely scheduled European quantum industry gathering of the autumn. The two-day event is co-hosted by a Danish Consortium comprising the **Ministry of Foreign Affairs of Denmark, Novo Nordisk Foundation, Novo Holdings, and 55 North**, all named as Platinum Sponsors in the announcement. More than 30 exhibitors are confirmed, including [Microsoft](https://quantumintel.tech/companies/microsoft), [Quantinuum](https://quantumintel.tech/companies/quantinuum), [Atom Computing](https://quantumintel.tech/companies/atom-computing), [IQM Quantum Computers](https://quantumintel.tech/companies/iqm-quantum-computers), [Classiq](https://quantumintel.tech/companies/classiq), [Multiverse Computing](https://quantumintel.tech/companies/multiverse-computing), [AWS](https://quantumintel.tech/companies/amazon-web-services), and [NVIDIA](https://quantumintel.tech/companies/nvidia). Pharmaceutical heavyweights AstraZeneca, Boehringer Ingelheim, and Merck are confirmed as industry speakers — a signal that enterprise buyers in drug discovery are now active enough participants in the quantum ecosystem to anchor a major conference program, not just attend as observers. A dedicated VC panel on day two, hosted by Needham & Company's quantum investment banking practice, will feature investors from 55 North, Deep33, Quantonation, Firgun Ventures, and Qbeat Ventures.

---

## What Is Q2B Copenhagen and Who Is Behind It?

Q2B Copenhagen is organized by **QC Ware**, the San Francisco-based quantum software company whose Promethium platform targets GPU-accelerated quantum chemistry for molecular modeling and drug discovery. QC Ware runs Q2B conferences in Japan, Europe, and the United States, positioning the series as the commercial counterpart to more research-oriented academic venues.

The Danish co-host structure is worth examining closely. Novo Nordisk Foundation and Novo Holdings — the financial and philanthropic arms of the broader Novo group — have a direct interest in quantum-accelerated pharmaceutical discovery, particularly molecular simulation and materials design. Their presence as Platinum Sponsors alongside the Danish foreign ministry signals that Copenhagen's quantum investment strategy is being coordinated across both public and private balance sheets. That's a more integrated approach than most European nations have managed.

QC Ware CEO Matt Johnson framed it plainly in the conference announcement: the event is designed to showcase how the Nordic region is driving Europe's leadership in the global quantum competition and accelerating the path from scientific output to commercial deployment.

---

## Program Structure: From Ambassador Panels to Startup Pitches

The conference opens with a panel of ambassadors on international quantum cooperation, moderated by **Louise Lund Henneberg**, Acting Director of the Department for Techplomacy at the Danish Ministry of Foreign Affairs. The session will address talent pipelines, funding gaps, government's role in commercialization, and the mechanics of international collaboration — topics that matter acutely as quantum supply chains become geopolitically sensitive.

**Day one** also hosts the **Start-up Pitch Competition**, organized by BioInnovation Institute, where early-stage companies will pitch to investors, corporates, and researchers. No finalist list was provided in the source material ahead of publication.

**Day two** features the VC panel hosted by **Steven Camp**, Managing Director of Quantum Investment Banking at **Needham & Company** — one of the few investment banks with a dedicated quantum practice. The investor roster (55 North, Deep33, Quantonation, Firgun Ventures, Qbeat Ventures) spans European and transatlantic early-stage quantum capital, giving founders a concentrated access window to backers who are actively writing quantum checks.

Technical content spans [hybrid quantum-classical](https://quantumintel.tech/glossary/hybrid-quantum-classical) workflows, error correction, optimization, quantum sensing, communications, and security. The breadth is consistent with Q2B's format — this is not a hardware-depth conference in the style of APS or QIP, but a deliberately cross-layer event designed to accelerate the interface between hardware progress and enterprise adoption.

---

## The Denmark Quantum Ecosystem: Substance Behind the Branding?

State Secretary for Trade and Investments **Susanne Hyldelund** stated in the announcement that Denmark has positioned itself as a leading European quantum hub connecting research with industry adoption through strategic investment and public-private collaboration.

That framing deserves some scrutiny. Denmark's quantum ecosystem is real but still maturing. The country benefits from strong university research infrastructure and the Novo group's financial firepower, but it does not yet host a domestically headquartered quantum hardware company with the profile of a Quantinuum, IQM, or pasqal. What Copenhagen does have is a credible convening role — the ability to attract global players to a well-resourced, politically supported venue — and the presence of Novo's capital as a potential anchor for deeper investment in the sector. Whether the Q2B partnership translates into durable funding commitments or remains a diplomatic showcase is a question this conference won't fully answer, but the roster of attendees will be a leading indicator worth watching.

The Techplomacy framing — an actual department name within the Danish foreign ministry — reflects a broader European recognition that quantum technology is now a foreign policy asset, not merely a research investment.

---

## Industry Significance: What the Vendor List Reveals

The exhibitor list at a major quantum conference is one of the more honest signals of commercial maturity in the sector. This year's Q2B Copenhagen list includes hardware vendors ([Atom Computing](https://quantumintel.tech/companies/atom-computing), [IQM](https://quantumintel.tech/companies/iqm-quantum-computers), [Quantinuum](https://quantumintel.tech/companies/quantinuum), C12, ZuriQ, kiutra), software and algorithm companies (Classiq, [Multiverse Computing](https://quantumintel.tech/companies/multiverse-computing), Phasecraft, QC Design, Kvantify), cloud access providers ([Microsoft](https://quantumintel.tech/companies/microsoft), [AWS](https://quantumintel.tech/companies/amazon-web-services)), and specialized sensing and photonics vendors (Nvision Quantum Technologies, Hamamatsu Photonics). Fujitsu also appears — notable given the company's active European push in quantum simulation.

The pharmaceutical vertical representation (AstraZeneca, Boehringer Ingelheim, Merck on the speaker side; Novo Holdings on the sponsor side) is the most commercially meaningful cluster at the event. Quantum chemistry simulation — specifically the ability to model molecular [entanglement](https://quantumintel.tech/glossary/entanglement) effects in drug candidates beyond what classical methods handle efficiently — is the use case most frequently cited by pharma enterprise buyers as their primary quantum investment rationale. Having these companies in speaking roles rather than just attendance suggests they have results or roadmap positions worth sharing publicly.

---

## Key Takeaways

- **Q2B Copenhagen runs September 9–10, 2026** at Øksnehallen; registration is open now via the QC Ware conference site.
- The Danish Consortium co-hosts include **Novo Nordisk Foundation, Novo Holdings, the Ministry of Foreign Affairs of Denmark, and 55 North** — a mix of sovereign and private capital not commonly seen in European quantum event sponsorship.
- **30+ vendors confirmed**, spanning hardware, software, cloud, sensing, and photonics across multiple qubit modalities.
- **Pharma sessions** from AstraZeneca, Boehringer Ingelheim, and Merck make this one of the stronger quantum-chemistry-meets-enterprise programs in the European calendar this year.
- **VC panel on day two** with Needham's quantum investment banking lead and five active quantum-focused funds.
- A **startup pitch competition** organized by BioInnovation Institute targets early-stage companies seeking investor and corporate visibility.
- The conference covers computing, AI, sensing, communications, and security — broad by design, reflecting the cross-layer nature of quantum commercialization in 2026.

---

## Frequently Asked Questions

**When and where is Q2B Copenhagen 2026?**
The conference takes place September 9–10, 2026, at Øksnehallen in Copenhagen, Denmark, organized by QC Ware.

**Who is sponsoring Q2B Copenhagen 2026?**
The event is co-hosted by a Danish Consortium comprising the Ministry of Foreign Affairs of Denmark, Novo Nordisk Foundation, Novo Holdings, and 55 North, all serving as Platinum Sponsors alongside QC Ware as organizer.

**Which quantum hardware and software companies are exhibiting?**
Confirmed exhibitors include Microsoft, Quantinuum, Atom Computing, IQM, Classiq, Multiverse Computing, AWS, NVIDIA, Fujitsu, C12, ZuriQ, Phasecraft, Hamamatsu Photonics, Nvision Quantum Technologies, kiutra, and others.

**What industries are represented in the speaker program?**
Pharmaceuticals (AstraZeneca, Boehringer Ingelheim, Merck), telecommunications (NTT Data Group Corporation), finance and consulting (BCG.X), and energy (Alliander) are among the confirmed industry verticals in the program.

**Is there a startup competition at Q2B Copenhagen?**
Yes. The Start-up Pitch Competition, organized by BioInnovation Institute, takes place on September 9, with early-stage companies pitching to investors, corporates, and researchers from the quantum ecosystem.